TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 7 | 32 | 33 | 7 | 35 | -2 | 19 |
| P | %wins | 100 | 100 | 67 | 33 | 100 | 33 | 72 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/11/07 21:04 | 1/11/07 | RPRX | Repros Therapeutics Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Van As Andre Md, Phd | TX | O | Chief Me | P | 24 | 12.20 | 1 | 2 | 24 | 10 | D | 200 | 130 | 52 | 62 | 115 | 74 | -8 | 1 | 4 | 4 | -1 | -9 | 10 | -21 |
12/27/06 15:00 | 12/26/06 | RPRX | Repros Therapeutics Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Van As Andre Md, Phd | TX | O | Chief Me | P | 5 | 11.85 | 0 | 0 | New | 0 | I | 186 | 127 | 35 | 51 | 98 | 98 | 95 | 68 | 6 | 5 | 12 | -18 | 9 | -20 |
12/21/06 15:25 | 12/19/06 | RPRX | Repros Therapeutics Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Van As Andre Md, Phd | TX | O | Chief Me | P.d | 14 | 7.08 | 0 | 2 | 33 | 8 | D | 76 | 44 | -19 | -11 | 5 | 20 | 12 | 13 | 11 | 87 | 87 | 47 | 87 | 35 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |